A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2

Cancer Treat Rev. 1989 Jun:16 Suppl A:105-9. doi: 10.1016/0305-7372(89)90029-7.

Authors

J Wagstaff¹, J B Vermorken, G Schwartsmann, R J Scheper, C E Hack, J H Nuijens, A J Eerenberg-Belmer, H M Pinedo

Affiliation

¹ Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.

PMID: 2504491
DOI: 10.1016/0305-7372(89)90029-7

No abstract available

MeSH terms

Adult
Aged
Complement Activation
Drug Evaluation
Humans
Interferon-gamma / therapeutic use*
Interleukin-2 / adverse effects
Interleukin-2 / therapeutic use*
Middle Aged
Neoplasms / drug therapy*
Neoplasms / immunology

Substances

Interleukin-2
Interferon-gamma